ACTINIUM PHARMACEUTICALS, INC. Other Financial Services Costs (Deprecated 2018-01-31)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Other Financial Services Costs (Deprecated 2018-01-31) of $0 for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherFinancialServicesCosts · last filed 2011-11-14
- ACTINIUM PHARMACEUTICALS, INC. other financial services costs (deprecated 2018-01-31) for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. other financial services costs (deprecated 2018-01-31) for the quarter ending 2010-09-30 was $24.00.
| Period end | Other Financial Services Costs (Deprecated 2018-01-31) 3 month | Other Financial Services Costs (Deprecated 2018-01-31) 6 month | Other Financial Services Costs (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-12 | ||
| 2010-09-30 | $24.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $182.00 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $158.00 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |